Epidemiology of HPV cervical infections: Recent knowledge;Epidémiologie des infections cervicales à papillomavirus: Acquisitions récentes

Presse Medicale

Volumn 30, Issue 20, 2001, Pages 1017-1023

  Mougin, C ^a   Dalstein, V ^a   Pretet J L ^a   Gay, C ^a   Schaal, J P ^a   Riethmuller, D ^a  

^a Faculté de Médecine   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P105; PROTEIN P53; VIRUS PROTEIN;

CANCER PREVENTION; CANCER RISK; FEMALE; GENETIC PREDISPOSITION; HUMAN; IMMUNE STATUS; INFECTION PREVENTION; INFECTION RISK; LATENT PERIOD; NUTRITIONAL STATUS; PRECANCER; REVIEW; SEXUAL BEHAVIOR; SEXUAL TRANSMISSION; SMOKING; SOCIOECONOMICS; UTERINE CERVICITIS; UTERINE CERVIX CANCER; VIRUS EXPRESSION; VIRUS PATHOGENESIS; WART VIRUS;

ADULT; AGE FACTORS; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INCIDENCE; MASS SCREENING; MIDDLE AGED; ONCOGENES; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 0035832531     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (81)

1. Cancer of the uterine cervix
2. Epidemiology of cancer of the cervix: Global and national perspective
3. Comparison of human papillomavirus genotypes in archival cervical cancer specimens from Alaska natives, Greenland natives and Danish Caucasians
4. Cancer statistics, 1998
5. Cancer incidence and mortality trends among whites in the United States, 1947-84
6. L'incidence du cancer du col de l'utérus régresse régulièrement en France
7. Cervical screening adjuncts: Recent advances
8. Liquid-based cytology for primary cervical cancer screening: A multi- centre study
9. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective
10. Different risk factor patterns for high-grade and low-grade intraepithelial lesions on the cervix among HPV-positive and HPV- negative young women
11. Epidemiologic evidence and human papillomavirus infection as a necessary cause of cervical cancer
12. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
13. Human papillomavirus and cancer: The epidemiological evidence
14. Human papillomavirus infection and invasive cervical neoplasia: A study of prevalence and morphology
15. No serological evidence for non-sexual spread of HPV16
16. Epidemiology of genital human papillomavirus infection
17. A neglected lesbian health concern: Cervical neoplasia
18. Human papillomavirus-associated cervical intraepithelial neoplasia following lesbian sex
19. Genital human papillomavirus infection in women who have sex with women: A review
20. Failure to identify venereal disease in a lesbian population
21. Lesbians and cervical screening
22. Detection of human papillomavirus DNA on the fingers of patients with genital warts
23. The epidemiology of cervical carcinogenesis
24. Human papillomavirus DNA in fomites on objects used for the management of patients with genital human papillomavirus infections
25. Vertical transmission of human papillomavirus from infected mothers to their newborn babies and persistence of the virus in childhood
26. Cancer associated human papillomaviruses: Perinatal transmission and persistence
27. Cytokine expression in squamous intraepithelial lesions of the uterine cervix: Implications for the generation of local immunosuppression
28. Natural history of cervicovaginal papillomavirus infection in young women
29. Genital human papillomavirus infection among women recruited for routine cervical cancer screening or for colposcopy determined by Hybrid Capture II and polymerase chain reaction
30. Genital human papillomavirus infection in female university students as determined by a PCR-based method
31. Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions
32. A population-based five-year follow-up study of cervical human papillomavirus infection
33. Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions
34. Human papillomavirus infection is transient in young women: A population-based cohort study
35. Human papillomavirus (HPV) and cervical cancer
36. Cervicography screening for cervical cancer among 8460 women in a high- risk population
37. Biology of papillomavirus infections. I. General characteristics
38. Chromosome 4 deletions are frequent in invasive cervical cancer and differ between histologic variants
39. Cervical screening in genitourinary medicine clinics - What are we trying to achieve?
40. Cancer in husbands of cervical cancer patients
41. PCR based high risk HPV testing is superior to neural network based screening for predicting incident CIN III in women with normal cytology and borderline changes
42. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: A prospective study
43. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer
44. Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: A nested case-control study
45. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia
46. Human papillomavirus type 16 variants and risk of cervical cancer
47. Association between high-risk HPV types, HLA DRB1* and DQB1* alleles and cervical cancer in British women
48. Human papillomavirus type 16 E6 variants in cervical carcinoma: Relationship to host genetic factors and clinical parameters
49. HPV DNA testing in cervical cancer screening: Results from women in a high-risk province of Costa Rica
50. A cumulative case-control study of risk factor profiles for oncogenic and nononcogenic cervical human papillomavirus infections
51. Co-factors related to the causal relationship between human papillomavirus and invasive cervical cancer in honduras
52. Sexual behavior and partner characteristics are the predominant risk factors for genital human papillomavirus infection in young women
53. Determinants of low-risk and high-risk cervical human papillomavirus infections in Montreal University students
54. HPV types. Natural history and epidemiology
55. Smoking, diet, pregnancy and oral contraceptive use as risk factors for cervical intra-epithelial neoplasia in relation to human papillomavirus infection
56. Causes of cervical cancer in the Philippines: A case-control study
57. The biology of papillomavirus infections. III. Immune response
58. HPV subtype analysis in lower genital tract neoplasms of female renal transplant recipients
59. Evaluation of the risk of cervical intraepithelial neoplasia and human papilloma virus infection in renal transplant patients receiving immunosuppressive therapy
60. Squamous cell carcinomas after allogeneic bone marrow transplantation for aplastic anemia: Further evidence of a multistep process
61. Human papillomavirus infection and anogenital condyloma in bone marrow transplant recipients
62. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women
63. Effect of HIV infection on the natural history of anal human papillomavirus infection
64. Squamous intraepithelial lesions (SILs) and HPV associated changes in HIV infected women or at risk of HIV
65. A matched prospective study of human immunodeficiency virus serostatus, human papillomavirus DNA, and cervical lesions detected by cytology and colposcopy
66. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome
67. Association of human papillomavirus infection and disease with magnitude of human immunodeficiency virus type 1 (HIV-1) RNA plasma level among women with HIV-1 infection
68. Colposcopy, cytology and HPV-DNA testing in HIV-positive and HIV- negative women
69. Increased risk of cervical disease among human immunodeficiency virus- infected women with severe immunosuppression and high human papillomavirus load (1)
70. Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapy
71. 1998 Guidelines for treatment of sexually transmitted diseases
72. Role of a p53 polymorphism in the development of human papillomavirus- associated cancer
73. The p53 Arg72Pro polymorphism, human papillomavirus, and invasive squamous cell cervical cancer
74. Analysis of human papillomavirus type 16 E6 variants in relation to p53 codon 72 polymorphism genotypes in cervical carcinogenesis
75. Chemoprevention trials and surrogate end point biomarkers in the cervix
76. Serum retinol level and risk of subsequent cervical cancer in cases with cervical dysplasia
77. Association of vitamin A deficiency with cervical squamous intraepithelial lesions in human immunodeficiency virus-infected women
78. Biology of the papillomavirus infections: V. Vaccine developments